Stock SPRY ARS PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Transcripts ARS Pharmaceuticals, Inc.

Equities

SPRY

US82835W1080

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-05-13 EDT 		5-day change 1st Jan Change
8.89 USD +1.72% Intraday chart for ARS Pharmaceuticals, Inc. -5.93% +62.23%
05-09 ARS Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-30 ARS Pharmaceuticals, Inc. Submits Response for Neffy (Epinephrine Nasal Spray) Marketing Authorization Application to EMA's Chmp CI

Transcripts

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Transcript : ARS Pharmaceuticals, Inc., Silverback Therapeutics, Inc. - M&A Call
Transcript : Silverback Therapeutics, Inc. Presents at H.C. Wainwright BioConnect Conference, Jan-10-2022 07:00 AM
Transcript : Silverback Therapeutics, Inc. - Special Call
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SPRY Stock
  4. News ARS Pharmaceuticals, Inc.
  5. Transcripts
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW